Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe

Given the current financial climate there is an ever increasing need to substitute drug treatments to optimize\udexpenditure. A closer examination of the beliefs surrounding\udwhen substitution is appropriate led a group of European\udhealthcare experts to argue that in some cases these\udbeliefs may be unfounded and that guidelines are needed\udfor clinical practice